Mucocutaneous toxicities are often observed during chemotherapy, in particular during therapy with targeted drugs, causing significant morbidity. The prevention and treatment of these toxicities are important not only to improve quality of life (QoL) but also to avoid unnecessary dose reduction or interruption, which can have a negative effect on treatment outcome. Proactive dermatologic treatment can reduce skin's toxicity grade and consequently clinical outcomes, compliance, and QoL in patients with advanced colorectal cancer.

Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience

Chiodini P.;Annunziata M. C.;Peduto T.;Fabbrocini G.
2020

Abstract

Mucocutaneous toxicities are often observed during chemotherapy, in particular during therapy with targeted drugs, causing significant morbidity. The prevention and treatment of these toxicities are important not only to improve quality of life (QoL) but also to avoid unnecessary dose reduction or interruption, which can have a negative effect on treatment outcome. Proactive dermatologic treatment can reduce skin's toxicity grade and consequently clinical outcomes, compliance, and QoL in patients with advanced colorectal cancer.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/849554
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact